Trademark: 97477128
Word
SELARSDI
Status
Pending
Status Code
730
Status Date
Thursday, January 4, 2024
Serial Number
97477128
Mark Type
4000
Filing Date
Monday, June 27, 2022
Published for Opposition
Tuesday, May 16, 2023

Trademark Owner History
Teva Pharmaceuticals USA - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications

Trademark Events
Jan 4, 2024
Sou Extension 1 Granted
Jan 4, 2024
Sou Extension 1 Filed
Jan 4, 2024
Sou Teas Extension Received
Jul 11, 2023
Noa E-Mailed - Sou Required From Applicant
May 16, 2023
Official Gazette Publication Confirmation E-Mailed
May 16, 2023
Published For Opposition
May 4, 2023
Teas Change Of Correspondence Received
May 4, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
May 4, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 26, 2023
Notification Of Notice Of Publication E-Mailed
Apr 11, 2023
Approved For Pub - Principal Register
Apr 11, 2023
Assigned To Examiner
Feb 22, 2023
Teas Change Of Correspondence Received
Feb 22, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 22, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 22, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 14, 2022
New Application Office Supplied Data Entered
Jun 30, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24